跳至主要内容
临床试验/ACTRN12610000776000
ACTRN12610000776000招募中未知

The use of novel protein biomarkers in predicting clinical outcomes in patients with localised and metastatic colorectal cancer

Cancer Institute NSW0 个研究点目标入组 200 人开始时间: 2010年9月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients with biopsy proven metastatic or locally advanced colorectal cancer starting chemotherapy involving infusional 5-fluoroouracil or
  • Patients with biopsy proven metastatic colorectal cancer for symotomatic management only
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2 AND
  • age over 18 years AND
  • ability to comply and provide informed written consent

排除标准

  • Pior chemotherapy for metastatic colorectal cancer or adjuvant chemotherapy in the last 6 months
  • Other active malignancy
  • Active autoimmune, inflammatory disease or infection
  • Symptoms and signs of cancer cachexia

研究者

发起方
Cancer Institute NSW

相似试验